Knowledge sharing between organization leaders to share information and explore opportunities for cross tumor collaborations, and increasing knowledge about, access to, and appropriate use of the latest oncology precision medicine tools.
Key Activities
Q2 Panel: Evolution of Genetic Testing (May 20, 2026); Q4: Use of AI for patients to understand biomarker and genetic testing. Cancer Biomarker Awareness Day (Nov 12, 2026). Convenes three working groups: Access (reimbursement and non-reimbursement barriers), Patient Education, and Health Equity.